超脂血症引发的中性恋会促进早期动脉样硬化
Maik Drechsler1, Remco T A Megens, Marc van Zandvoort
1Institute for Molecular Cardiovascular Research, Pauwelsstrasse 30, 52074 Aachen, Germany.
Circulation
|October 20, 2010
概括
高胆固醇会导致中性粒细胞的增加,而中性粒细胞是动脉样硬化早期发展的关键. 减少中性粒细胞减少了早期斑块的生长,突出了它们在引发这种心血管疾病中的作用.
科学领域:
- 心血管研究研究心血管研究
- 免疫学 免疫学 免疫学
- 动脉样硬化病原体的产生
背景情况:
- 炎症和免疫细胞激活是动脉样硬化的主要原因.
- 单细胞和T淋巴细胞是已知的动脉样硬化病变形成的贡献者.
- 中性粒细胞在动脉样硬化开始和进展中的特定作用需要进一步阐明.
研究的目的:
- 为了研究高胆固醇血症对外围中性粒细胞数量的影响.
- 为了检查对动脉样硬化病变的中性粒细胞的招募.
- 确定中性粒细胞在阿波埃小鼠动脉硬化病变发展中的重要性.
主要方法:
- 在使用高脂肪饮食的阿波小鼠中诱导高胆固醇血症.
- 对外围中性粒细胞数量和骨髓动员的量化.
- 通过流细胞测量对中性粒细胞透到动脉样硬化病变的分析.
- 评估中性贫血小鼠与对照小鼠的斑块大小和组成.
主要成果:
- 高胆固醇血症导致中性粒细胞数量增加 (中性粒细胞) 由于增强的颗粒形成和骨髓动员.
- 中性恋与早期动脉样硬化病变的发展正相关.
- 中性贫的小鼠在早期阶段表现出减少的斑块大小,单细胞和巨细胞的数量发生了变化.
- 中性粒细胞在动脉中的招募在4周达到峰值,并取决于特定的化学因受体 (CCR1,CCR2,CCR5,CXCR2).
结论:
- 高胆固醇血引起的中性恋是一种复杂的过程.
- 中性粒细胞主要在动脉样硬化的早期阶段入动脉.
- 中性粒细胞在动脉样硬化开始过程中起着重要作用.
相关概念视频
Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Inflammation
Overview
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

